• Global alternative fuel and hybrid vehicle market is expected to grow to $614 billion by 2022, registering a compound annual growth rate (CAGR) of nearly 13 percent
• Greenkraft’s eco-friendly commercial trucks and alternative fuel systems offer environmentally friendly solutions with a price advantage and American performance
• California legislators are poised to increase funding for state’s purchase of alternative fuel-fed vehicles and trucks

Greenkraft, Inc. (OTCQB: GKIT), a nationally recognized company specializing in the production of alternative fuel automotive products, engines and commercial trucks, continues its revolutionary work on manufacturing cost-efficient commercial trucks powered by alternative fuels. Based in Santa Ana, California, Greenkraft’s expansion plans include construction of a larger manufacturing facility to accommodate this increasing demand for fuel-efficient trucks with varying carrying capacities.

Most vehicles, especially commercial trucks, are powered by either gasoline or diesel, but this trend is beginning to change. The U.S. government is funding several efforts to help consumers find the alternative fuel or fuel-efficient solutions that meet their needs. In California, legislators recently reached an agreement to direct up to $1.5 billion of revenue from the state’s greenhouse gas emissions allowance to expand its use of alternative transportation fuels, according to Natural Gas Intelligence, an industry publication (http://dtn.fm/PLX7n). In the legislative deal, nearly $900 million is earmarked for alternative fuel vehicles – including trucks and buses – purchased by the state.

California’s push to “move toward a future where trucks and buses produce either zero or virtually zero emissions” is at a pivotal point, according to an industry group in support of the increased funding. Several major U.S. cities are already using Greenkraft’s fuel-efficient trucks for their daily operations. These trucks not only produce fewer pollutants and less of an environmental impact; they also save these cities a healthy amount of money.

The world’s alternative fuel and hybrid vehicle market is expected to grow at a blistering pace over the next five years, reaching upward of $614 billion by 2022 and registering a nearly 13 percent compound annual growth rate, according to a report by Allied Market Research (http://dtn.fm/ei0Xl). Technological advances in alternative fuel vehicles and proactive government initiatives, such as the one under consideration in California, are helping to propel the market’s stunning growth.

Greenkraft CEO George Gemayel recently noted that the company’s ability to offer its truck line in sizes ranging from 14,500 lbs. to 33,000 lbs. makes sense for a variety of industries, including those needing refrigeration options. Greenkraft’s CNG trucks are becoming the standard alternative to diesel trucks in the United States.

“This increased demand and national recognition of our CNG truck line is set to dramatically increase GKIT’s revenue in the 2017 fiscal year,” Gemayel stated in a news release.

For more information, visit the company’s website at www.GreenkraftInc.com

Let us hear your thoughts: Greenkraft, Inc. Message Board

• Exploration of Bristol Lake Project reveals excellent lithium-bearing brine harvest potential
• Global lithium compounds market projected to reach U.S. $5.87 billion by 2020
• Technological advances provide access to low cost, battery-grade lithium materials
• World demand for lithium expected to increase 300% by 2025

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) is a Canadian-based energy exploration and development company that is building one of the largest portfolios of high quality, domestic U.S. lithium brine assets. Its data and technology driven project development model is grounded in knowledge, opportunity and speed. Standard Lithium is led by an innovative and results-oriented management team with a strong focus on technical skills. The company has acquired several prospective lithium brine projects with known geological values consistent with producing basins, including its primary focus, the Bristol Dry Lake, California brownfield project that is permitted for related mineral production with accompanying world class infrastructure which are expected to contribute to faster, lower cost exploration and commercial development programs.

Recent results from a geophysical survey of the 25,000-acre Bristol Lake site suggest a high concentration of lithium-bearing brines are present throughout the company’s mineral lease agreement claims. Standard Lithium’s strategic partner in the venture, National Chloride Corporation of America, is well established in the region. All necessary infrastructure is on site, which gives Standard Lithium immediate access to conduct exploration brine sampling, lithium extraction, evaporation and processing activities, all within a fast-track project development schedule.

World demand for lithium continues to surge. The global lithium compounds market is projected to reach U.S. $5.87 billion by 2020, at a compound annual growth rate of 13.22% between 2015 and 2020. Lithium-ion batteries are the fastest growing segment of the market.

Standard Lithium’s determination to provide battery-grade lithium materials is bolstered by its recently appointed Scientific Advisory Council. These leading lithium extraction scientists and process engineers will oversee and direct the necessary lithium extraction process testing work. In addition to the Bristol Lake Brine Project, the company signed a Memorandum of Understanding in August with an unnamed New York Stock Exchange-listed company on an option for Standard to acquire lithium exploration and productions rights on 30,000 net brine acres overlying the Smackover formation in a region with a history of commercial-scale brine processing. Management believes lithium-bearing brines are likely present in this area. Smackover brines are metal-rich brine anomalies in reservoir rocks along the Gulf Coast from east Texas to Florida known to be a prime lithium resource. This resource may be one of the most promising ones to develop, given that a large-scale brine extraction, processing and reinjection industry is already well established.

Recently, Standard Lithium closed a multi-million dollar private placement offering, which allows the company to advance its current projects and pursue strategic acquisitions in the lithium sector. The company is well positioned with significant exploration opportunities featuring low cost production costs, easy transport, proximity to demand, and access to innovative production methodology.

For more information, visit the company’s website at www.StandardLithium.com

• 92 Resources is an emerging junior exploration company
• Worldwide market for lithium is projected to grow 8.9% annually through 2019 to reach $1.7 billion
• Lithium-ion rechargeable batteries are used in the manufacture of electric vehicles, phones, laptops and digital cameras

92 Resources Corp. (TSX.V: NTY) (OTCQB: RGDCF) (FSE: R9G2) recently announced that it has acquired three new properties in Quebec, Canada, which are highly prospective in hard-rock lithium (http://dtn.fm/5xCgg). The sites are Corvette, Eastmain, and Lac du Beryl, and consist of 115 mineral claims on a combined 14,710 acres.

92 Resources is an emerging junior exploration company focused on acquiring and advancing strategic and prospective assets. It acquired 100% interest in the Hidden Lake Lithium Property and has achieved 97% lithium extraction from its pegmatites. Lithium is used for the manufacture of rechargeable lithium-ion batteries in phones, laptops, digital cameras and electric vehicles. Aluminum-lithium alloys are used in the manufacture of aircraft, bicycle frames and high speed trains. The global market for lithium is projected to grow 8.9% annually through 2019 to reach $1.7 billion, according to The Freedonia Group (http://dtn.fm/nPR96).

In a news release, Adrian Lamoureux, president and CEO of 92 Resources, said, “As we continue to aggressively advance our flagship Hidden Lake Lithium Project in NWT, we feel it is critical to maintain a pipeline of additional high-quality, early staged lithium pegmatite projects, each with potential as stand-alone properties. We are very excited by these new additions to the Company’s already high quality portfolio of assets”

In its corporate presentation (http://dtn.fm/pWKG0), 92 Resources explained that pegmatite is a type of crystal-heavy igneous rock and that hard rock lithium represents about one-third of all global reserves.

Brief due diligence site visits were made prior to the acquisition and pegmatite outcrop was confirmed at each property.

At the Corvette Project, 76 claims have been made. At the site visit, abundant coarse-grained spodumene crystals were identified. On the Eastman Project, 21 claims have been made, and it is highlighted by a large pegmatite outcrop. A total of 18 claims have been made at the Lac du Beryl Project, where several prominent outcrops of pegmatite have been seen.

For more information, visit the company’s website at www.92Resources.com

Let us hear your thoughts: 92 Resources Corp. Message Board

• Encouraging results noted for pancreatitis patients with exocrine pancreatic insufficiency
• Early data shows favorable safety profile, positive dose tolerance
• Favorable trends observed in other identified markers
• Study is being performed at four sites in Australia and New Zealand

New York-based AzurRx BioPharma Inc. (NASDAQ: AZRX), a biopharmaceutical company engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders, recently announced positive results from its ongoing clinical trials of MS1819-SD, a recombinant lipase, developed for the treatment of exocrine pancreatic insufficiency (EPI) caused by chronic pancreatitis.

In an update issued last week (http://dtn.fm/njK0J), AzurRx BioPharma said clinical trials of the first six patients being treated with MS1819-SD underway in Australia and New Zealand are showing encouraging results. Importantly, the company said patients showed a positive dose response curve and a 21% improvement in the coefficient of fat absorption in evaluable patients. The response rate went as high as 57% in one of the patients, and higher response rates were noted in patients with lower baseline CFA levels. Favorable trends were also observed in other endpoints with no serious adverse events reported.

“We are encouraged by these Phase IIa data,” Thijs Spoor, CEO of AzurRx BioPharma, stated in the news release. “They further confirm the activity of MS1819-SD and also demonstrate its dose response characteristics. Additionally, secondary efficacy endpoints are consistently aligning with the CFA data and the safety profile of MS1819-SD remains favorable.”

The primary objective of the phase IIa study is to investigate the safety of escalating doses of MS1819-SD in patients with chronic pancreatitis. The secondary objective is to investigate the efficacy of MS1819-SD in these patients by analysis of the coefficient of fat absorption and its change from baseline. Patient safety is of paramount importance and is assessed at the end of each treatment period, with attention being paid to immunoallergic effects, digestive symptoms and clinical laboratory results.

AzurRx Biopharma expects to enroll 12-15 patients in this open-label phase IIa trial of MS1819-SD, which is being conducted in partnership with Mayoly Spindler, a European pharmaceutical company. There are approximately 100,000 patients in the U.S. with EPI caused by chronic pancreatitis, according to the National Pancreas Foundation, with another estimated 30,000 patients with EPI caused by cystic fibrosis, the Cystic Fibrosis Foundation reports. When the pancreas can’t properly break down foods, poor digestion and malnutrition is the result. Patients with this condition are currently treated with porcine (derived from pig) pancreatic enzyme replacement pills.

The National Institutes of Health, analysts on Wall Street and the National Pancreas Foundation estimate the yearly market for pancreatic enzyme replacement therapy to be well over $800 million in the U.S. and at least $1.5 billion globally.

For more information, visit the company’s website at www.AzurRx.com

• Greenkraft is the only company to manufacture both CNG- and LPG-powered trucks
• Among few companies in the world to offer a refrigeration option for alternative fuel trucks
• Company has experienced a significant uptick in orders from fleet operators during 2017

Aiming to become the leading provider of alternative fuel trucks in North America, Greenkraft, Inc. (OTCQB: GKIT) is at the head of its class in introducing alternative fuel products that are both cost-effective and of the highest quality. The company was founded in 2008 with the objective of manufacturing alternative commercial forward cab trucks and alternative fuel systems for a variety of vehicles. Greenkraft’s commercial trucks operate under the power of alternative fuels CNG and LPG in classes 4, 5, 6 and 7.

The way is clear for Greenkraft to become number one in its field, as the company controls almost of all of the market share in the clean energy truck market. Greenkraft is currently the only manufacturer to offer trucks that are powered by both CNG and LPG, and electric vehicles are also forthcoming, according to the company’s website.

Greenkraft’s products include commercial trucks, alternative fuel systems and eco-friendly engines, all of which are environmentally friendly automotive solutions. The company’s products boast price advantages, American craftsmanship, enviro-friendliness and exceptional efficiency.

Greenkraft’s commercial trucks feature a cab forward design that enables the passenger area to be considerably larger than one finds in other similarly-sized vehicles. Several options are also offered regarding tank capacity, letting customers choose the most efficient model for their needs. Greenkraft is additionally one of the only companies on Earth that offers an alternative fuel truck with a refrigeration option.

Demand for Greenkraft’s trucks has greatly increased this year as orders have poured in from fleet operators throughout the United States. The various government incentives offered for companies that change over to alternative-fuel trucks have helped fuel this surge. Many of the fleet operators interested in Greenkraft’s pioneering trucks also operate their own filling stations, through which they are able to get CNG at low prices.

During 2017, Greenkraft has been executing a clear-cut growth plan, which has included the expansion of the company’s factory as well as the introduction of a new line of trucks—the G3 and G4—which will accommodate respective weights of 26,000 and 33,000 pounds.

For more information, visit the company’s website at www.GreenkraftInc.com

Let us hear your thoughts: Greenkraft, Inc. Message Board

• Wholly owned zinc project has estimate of 3.7 million tons of indicated resources and 4.09 million tons of inferred resources
• 525 acres of mineral rights includes zinc with significant assets of copper, silver and gold
• Advanced-stage project led by experienced management team with key technical advisors
• Global shortfall in zinc production equals significant opportunity

Blue Moon Zinc Corp. (TSX.V: MOON) (OTC: BMOOF), a mineral exploration company, is focused on developing its advanced-stage, wholly owned Blue Moon zinc project in central California. The project sits within Mariposa County, an area of active mines and exploration projects since it was part of the California gold rush era. Blue Moon’s 525 acres of mineral rights are assigned to patented and unpatented claims accessible by a gravel road off a nearby highway with main utility lines nearby.

The Blue Moon deposit is one of many located in the Foothills Massive Sulphide Belt in the Sierra Nevada Mountains of California. The property has a long history of exploration and saw small-scale mining during World War II. The current project, to be mined by underground methods, contains an estimated 3.70 million tons with a grade of 8.33% zinc equivalent for approximately 377 million pounds of zinc in the indicated category and another 4.09 million tons with a grade of 7.84% zinc equivalence for approximately 395 pounds of zinc in the inferred category. Significant bi-products of copper, silver and gold are also indicated. The deposit is open at depth and along strike with a high likelihood of expansion.

Current spot prices for zinc is approximately $1.40 per pound, which increases the potential returns of the Blue Moon project.

The historical database shows extensive plans to put the Blue Moon project into production, including several scoping and optimization studies. Past environmental work performed, along with an historical permit and reclamation plan approved for certain underground development, highlights past local county support for the project. These historical studies and permits are expected to help fast track the project’s progress as they form an excellent base for the upcoming Preliminary Economic Assessment and later feasibility study.

Among the significant historical studies conducted is a 1998 metallurgical report that shows recovery rates of 95 percent for zinc and lead, 93 percent for copper, 65 percent for silver and 70 percent for gold (http://dtn.fm/F3AhW). The report indicates that simple processing methods will produce premium concentrates with easy separation of the economic minerals.

Blue Moon CEO Patrick McGrath, who has 20 years of experience in financing and executive roles in the junior mining public sector, is joined by a management team with successful track records in leading and participating in significant mineral discoveries with development-stage mining companies. The Blue Moon team also includes a member who permitted and built the Soledad mine in southern California in 2016 and a member who re-started the Mesquite mine in southern California. Local knowledge and know-how is key. The company also plans to engage a recognized third-party engineering firm to prepare a preliminary economic assessment report, expected for release in the first quarter of 2018, to demonstrate the economic viability of the Blue Moon mineral resources.

For more information, visit the company’s website at www.BlueMoonMining.com

Let us hear your thoughts: Blue Moon Zinc Corp. Message Board

• Nearly 2 million acres of brine-bearing formations acquired to date
• Successfully extracted lithium from oilfield wastewater brine using proprietary process
• Wastewater treatment industry projected to grow into $45 billion market annually by 2025
• Diversified portfolio of lithium, magnesium and silicon assets in North America
• Global lithium-ion battery market projected to reach $93 billion by 2025

MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) is a diversified Canadian resource company developing large-scale mineral portfolios in specific commodities and jurisdictions in North America. The company controls significant interest in lithium, magnesium and silicon assets that offer streamlined development timelines and low capital expenditures. MGX Minerals and its engineering partner have developed a patent-pending, low-energy design process to extract valuable minerals from the abundant, highly mineralized brine wastewater produced each year by oil and gas companies.

This proprietary, petrolithium process rapidly concentrates lithium and other minerals from brine in less than a day. That’s a stunning advancement from the conventional method of extracting minerals from brine through an evaporation process that can take up to 18 months, requires hundreds of acres of land, and averages less than a 50 percent mineral recovery rate. Using this advanced water purification technology, MGX Minerals cleans the wastewater that accompanies petroleum as it’s being pulled up to the surface. The company’s petrolithium process eliminates the need to inject contaminated wastewater back into the ground, which prevents drinking water contamination and possible earthquakes.

In January 2017, MGX Minerals successfully recovered concentrated lithium from heavy oil evaporator blowdown wastewater using its rapid recovery process, an accomplishment independently confirmed by the Saskatchewan Research Council. In August 2017, the company also successfully processed wastewater and lithium brine from eight North American projects at its one-cubic-meter-per-hour processing plant, proving the technology is economically viable. Research group Global Water Intelligence expects the wastewater treatment industry to grow into a $45 billion market annually by 2025, which suggests there are ample revenue-generating opportunities for MGX Minerals technology.

Lithium, the “white gold” of the new energy economy, is the key to clean energy development as global demand for hybrid and electric vehicles, high-drain portable electronic devices, and large-scale energy storage systems ramps up. Grand View Research, Inc. reports that the global lithium-ion battery market is expected to reach $93.1 billion by 2025. Current market forces show a high demand for lithium and a low supply, which further supports the necessity of MGX Mineral’s cleaner, faster method of extracting high-value minerals from brine wastewater.

MGX Minerals is led by a team of industry standout performers who have worked in the mining and technology industries for decades. The leadership team is joined by an array of top-notch technical partners with unmatched experience in the oil and gas sectors, environmental services industry, marketing and product development, along with applied research and commercial development of technologies.

For more information, visit the company’s website at www.MGXMinerals.com

Let us hear your thoughts: MGX Minerals Inc. Message Board

• Nearly half of consumers in China pay using mobile devices
• Three-quarters of online payments come through mobile accounts
• Moxian’s apps serve consumers and businesses in the O2O market

The current trends in the global market are encouraging to investors, as consumers increasingly use mobile devices to connect with businesses and make purchases. Moxian, Inc. (NASDAQ: MOXC) recently cited data published by Nielson, in its Global Mobile Money Report (http://dtn.fm/KaG5y), indicating that, in China, nearly half of consumers are likely to use a device when paying a bill at a restaurant, store or bar. The ratio is even higher than in the U.S. and Europe. Mobile payments are growing on a global scale. A forecast by Allied Market Research, in its Mobile Payments Market Report, predicts that the global market may surpass $3.3 billion by 2022, expanding at a compound annual growth rate of 33.4 percent from 2016 to 2022 (http://dtn.fm/5o3Su).

The highest growth, according to the report, is expected to be in the Asia-Pacific region. Moxian has been well aware of the cashless trend in China. It serves the online-to-offline (O2O) market with its Moxian User App and Business App. Both of these feature UnionPay’s payment gateway. This integral system works with Moxian’s MO-Coin and MO-Points virtual currency, so consumers can take advantage of rewards features in the latest app versions.

The User App enables customers to earn MO-Coins by playing games, which they can redeem for prizes. This functionality enables merchants to run their marketing campaigns and advertise to their customers. It helps to learn a great deal about consumer behavior, while users can search for local merchants and obtain news and communicate with friends using the app’s media messenger. Moxian’s Multi-Channel Social Commerce Platform further digs into customer data using business intelligence, social media and entertainment.

Featuring a Social Customer Relationship Management Tool, the Moxian Business App is helping serve the regional market by providing merchants with the ability to establish virtual stores on the company’s platform. It supports various methods of promotion. In addition, customized reports are generated to provide business with insights into purchasing and other customer activity.

Businesses can also leverage automated data analytics tools. The app captures data automatically, so retailers can get the most out of the tools available. These include a loyalty tool that helps enhance marketing strategies. Companies can advertise directly through the platform, as well using a variety of media.

China has 1.3 billion residents. A large number of them use smartphones, and three-quarters of all online payments are sent through mobile accounts, according to analyst estimates. Spending through mobile payment platforms in 2016 was 50-times as much as in the U.S. Consumers are increasingly opting to use resources such as the Moxian O2O marketplace rather than cash. MOXC’s social marketing and promotion platforms enable merchants to target mobile users in their advertising and better interact with consumers. Given the increasing popularity of mobile payments, the company’s solutions are expected to help merchants to continue to grow.

For more information, visit the company’s website at www.Moxian.com

• Health conscious consumers favor cannabis oil extracts and edibles over smoking
• Recent survey shows 46% of Canadians would try cannabis-infused products
• Canadian cannabis oil extraction market expected to reach $1.7 billion by 2020

Algae Dynamics Corp (OTC: ADYNF) is uniquely positioned to benefit from the upcoming legalization of recreational marijuana in Canada by mid-2018. The company’s focus on developing proprietary research and products involving botanical oils derived from cannabis combines two important consumer demands – the well-known health benefits of cannabinoids and a smoke-free alternative to cannabis consumption.

Nearly half of Canadians (46%) polled in August 2017 by Dalhousie University researchers in Nova Scotia (http://dtn.fm/82V9p) said they are interested in trying edible marijuana once recreational marijuana is legalized within the country. To clarify, medical marijuana has been legal in Canada since 2001, with some provisions, and the new law will only allow consumers to purchase dried marijuana and cannabis oil.

The preliminary study, entitled “Cannabis-infused food and Canadian consumers’ willingness to consider marijuana as a food ingredient,” was led by Dr. Sylvain Charlebois, a professor in food distribution and policy on the Faculty of Management at Dalhousie University. Among the findings, the survey shows that the majority of the 1,087 Canadians (68%) surveyed are supportive of legalizing marijuana, and cannabis-infused baked goods, cannabis oils and spices are high on the list of things to try (http://dtn.fm/M9lHB).

Algae Dynamics and its marketing team are actively preparing to respond to an increased market demand once legalization takes place. The company cites a 2016 Mackie Research Capital Corp. estimate involving trends in Colorado, one of the first U.S. states to legalize marijuana, which found that 45% of dried marijuana users would eventually convert to marijuana extracts and/or oils. Algae Dynamics’ strategy includes extracting oils from cannabis and hemp to formulate unique health and nutraceutical products, along with the distinction of becoming a leading medical cannabis producer through its association with two of Canada’s leading research universities – the University of Waterloo and the University of Western Ontario. This collaborative research is focused on the use of extracts from cannabis oil in the context of various forms of cancer, in addition to development of new pharmacotherapies for mental health.

Algae Dynamics has also signed a letter of intent with a licensed cannabis producer that has the capability to grow multiple strains of the highly regulated plant in a state-of-the-art facility. This agreement with 6779264 Manitoba Ltd., dba Bonify, gives Algae Dynamics an improved pathway to early revenues as well as a high-quality source of cannabis oil to support the research already underway at the universities.

Cannabis oils are increasingly being seen by consumers as a much healthier avenue when it comes to cannabis consumption. The Canadian government has stated its intent to delay legalization of edibles past the planned July 1, 2018, deadline (http://dtn.fm/pVj8Z). Instead, the government indicates that it will focus on making products like fresh or dried cannabis, cannabis oils, seeds and plants available for legal purchase.

The underserved market for licensed cannabis producers in Canada, which currently has only 59 licensed producers to serve the country’s population of 35 million, offers great potential for Algae Dynamics. As part of its strategy to be the number one Canadian cannabis research-driven product formulator, Algae Dynamics relies on a formidable leadership team of scientific and strategic advisors that complement the company’s ongoing research and development relationships and initiatives.

For more information, visit the company’s website at www.AlgaeDynamics.com

Let us hear your thoughts: Algae Dynamics Corp. Message Board

• Product portfolio to include drugs and supplements
• Faster monetization of lead Alzheimer’s candidate as supplement
• Market valuation poised to soar

It should come as no surprise to discover that the medical cannabis dispensary product line in America is getting increasingly diverse and sophisticated. After all, the cannabis sativa plant incorporates over 400 chemical entities, of which more than 60 are cannabinoids. Even though cannabis has been used and cultivated by mankind for at least 6,000 years, it was only relatively recently, in 1899, that the first cannabinoid, cannabinol (CBN), was identified and isolated. With so much chemistry wrapped in its trichomes, colas and bracts, the range of ailments for which the plant promises palliatives continues to grow. Based on compelling data, India Globalization Capital, Inc. (NYSE MKT: IGC) was recently able to announce advances in the treatment of Alzheimer’s disease with THC. These encouraging results have brightened the company’s future, since the market for Alzheimer’s therapies is a billion-dollar one.

The IGC press release (http://dtn.fm/Va8MW) provided an update on in vitro data compiled from genetically engineered cell lines within an Alzheimer’s disease model, showing that, at varying concentrations of THC, the aggregation of Aβ protein decreases by as much as 40%. There are indications that at least one cause of AD may be the buildup of senile plaque composed of amyloid beta peptides (Aβ plaque) in the cerebral cortex and hippocampus. Over time, this plaque destroys neurons and causes synaptic dysfunction, leading to loss of memory.

“These study results, when combined with the earlier reported data that shows IGC-AD1 reduces Aβ40 and Aβ42 production by as much as 50%, and 40%, without any toxicity (http://dtn.fm/b3LDR), represent a highly significant novel breakthrough that could potentially bring much needed relief from this devastating disease,” Ram Mukunda, CEO of IGC, stated in a news release.

IGC stands to benefit in two ways: first, by taking IGC-ADI down the regular FDA route as both a prophylactic and a therapeutic; and second, as a food supplement to be sold in medical dispensaries. The FDA approach to a product labeled as a “drug” is different to one classified as a “supplement”. A drug is considered unsafe until proven otherwise by clinical trials, while a supplement, defined by the Dietary Supplement Health and Education Act (DSHEA) as food, is considered to be prima facie safe. This binal approach allows IGC to secure market share in the medical dispensary segment while IGC-AD1, named Hyalolex, works its way through the FDA approval process.

As IGC’s product initiatives come closer to market, the company is likely to attract increased attention that hoists its valuation in line with peers. Anavex Life Sciences (NASDAQ: AVXL), which recently completed a phase 2a trial of its lead product candidate in patients with mild to moderate Alzheimer’s disease, has a market cap of about $180 million. Its stock has traded between $2.60 and $6.31 over the past year. Shares of Axovant Sciences (NYSE: AXON), currently awaiting the results of a phase III trial for its lead Alzheimer’s candidate, have traded between $11.15 and $24.94 over the past year. The company’s current market cap is over $2.5 billion.

Also, AC Immune Ltd. (NASDAQ: ACIU), which is collaborating with Genentech/Roche, has its Alzheimer’s candidate in phase III. AC Immune’s stock has ranged from $6.70 to $19.30 over the past 12 months. The company is valued at around $381 million. Last but certainly not least is Biogen Inc. (NASDAQ: BIIB), recently added to Goldman Sachs’ (NYSE: GS) Equity Conviction List, which is valued at close to $61 billion. Its stock has traded between $246.00 and $329.00 this past year. Meanwhile, IGC stock currently trades around $0.36, and the company’s market cap is about $12.5 million.

For more information, visit the company’s website at www.IGCInc.us